Namur, Belgium, December 10, 2021 – Vésale Bioscience, a biotech company specializing in phage therapy, with a particular focus on research into alternative solutions to antibiotics and the development of treatments for multidrug-resistant infections, announces today that it has been awarded the prize for most innov.
Namur, Belgium, December 10, 2021 – Vésale Bioscience, a biotech company specializing in phage therapy, with a particular focus on research into alternative solutions to antibiotics and the development of treatments for multidrug-resistant infections, announces today that it has been awarded the prize for most innov.